🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Information and Costs

Inside these communities, posts show dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant health risks”.